Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rallybio Corp | 3,333,388 | reported | 15 Nov 2022 | tx 1+3,333,388 |
| PROCEPT BioRobotics Corp | 298,205 | reported | 18 Mar 2022 | tx 2−1,249,000 |
| Inhibrx Biosciences, Inc. | 67,018 | reported | 07 Oct 2025 | tx 3−350,000 |
| Frazier Lifesciences Acquisition Corp | 0 | reported | 22 Nov 2022 | tx 2−3,671,462 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Oct 2025 | SALE | Inhibrx Biosciences, Inc. | 16,315 | 32.25 USD | |
| 07 Oct 2025 | SALE | Inhibrx Biosciences, Inc. | 308,643 | 32.25 USD | |
| 07 Oct 2025 | SALE | Inhibrx Biosciences, Inc. | 25,042 | 32.25 USD | |
| 22 Nov 2022 | CONVERSION | Frazier Lifesciences Acquisition Corp | 1,211,582 | — | |
| 22 Nov 2022 | CONVERSION | Frazier Lifesciences Acquisition Corp | 2,459,880 | — | |
| 15 Nov 2022 | PURCHASE | Rallybio Corp | 3,333,388 | 6.00 USD | deriv |
| 18 Mar 2022 | SALE | PROCEPT BioRobotics Corp | 1,147,205 | 29.90 USD | |
| 18 Mar 2022 | SALE | PROCEPT BioRobotics Corp | 101,795 | 29.90 USD |